We are thrilled to announce that the BioPIC team has just been labeled “FRM Team 2022” for the next 3 years. Many thanks to the FRM (Fondation pour le Recherche Médicale) for their support in our research on AL amyloidosis and other pathologies associated with abnormal immunoglobulins.

A guarantee of excellence, the FRM label aims to provide strong and lasting support to teams proposing an innovative research program in biology with potential applications in health.